SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant (Q95622924)
Jump to navigation
Jump to search
scientific article published on 12 May 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant |
scientific article published on 12 May 2020 |
Statements
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant (English)
Yoriyuki Konno
Izumi Kimura
Keiya Uriu
Masaya Fukushi
Takashi Irie
Yoshio Koyanagi
So Nakagawa
Kei Sato
12 May 2020
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference